MALLORIE SKINNER: Open Payments
NPI 1154920239 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 60 payments from 18 companies in 2025. Trend: 2023 $697 · 2024 $730 · 2025 $1,153
Food & beverage: $1,153
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $227 |
| UCB, Inc. | 4 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| Grifols USA, LLC | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Electromed, Inc. | 4 | $85 |
| Philips North America LLC | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Novo Nordisk Inc | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
Products named: VRAYLAR, Bimzelx, Prolastin-C Liquid, TRELEGY ELLIPTA, SMARTVEST, OFEV, Vest Therapy Und, BREZTRI.
Industry payments across MI — which companies pay providers there.
